Modulating the developing gut microbiota with 2’-fucosyllactose and pooled human milk oligosaccharides
Our study provides valuable insight into the health-enhancing properties of HMOs while highlighting the need for future research into the efficacy of incorporating individual structures into infant formula, particularly when aiming to modulate the gut microbiota. Video Abstract.
Authors
- Mikael Knip (ORCID: https://orcid.org/0000-0003-0474-0033)
- Emma Allen‐Vercoe (ORCID: https://orcid.org/0000-0002-8716-327X)
- Annalee Fürst (ORCID: https://orcid.org/0000-0003-0406-8590)
- Lars Bode (ORCID: https://orcid.org/0000-0002-9914-9571)
- Jayne S. Danska (ORCID: https://orcid.org/0000-0002-6549-4991)
- Simone Renwick (ORCID: https://orcid.org/0000-0002-2786-893X)
Institutions
- University of Helsinki (FI)
- University of Toronto (CA)
- Helsinki University Hospital (FI)
- Hospital for Sick Children (CA)
- University of California San Diego (US)
- Helsinki Children's Hospital (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
- University of Guelph (CA)
Publication Details
- Journal
- Microbiome
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s40168-025-02034-9
- Citations
- 18
- Primary Topic
- Infant Nutrition and Health
- Type
- article
- Field-Weighted Citation Impact
- 20.15
Funders
- University of Guelph
- Juvenile Diabetes Research Foundation Canada
- Family Larsson‐Rosenquist Foundation
- European Commission
- Canada Research Chairs
- Academy of Finland
- University of Toronto
- Hospital for Sick Children
- University of California, San Diego
- Seventh Framework Programme
- Canadian Institutes of Health Research